Graf Akcie CSII (Cardiovascular Systems Inc.). Diskuze k akciím CSII. Aktuální informace CSII.

Základní informace o společnosti Cardiovascular Systems Inc. (Akcie CSII)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.33B
Hodnota podniku (EV) 1.21B
Tržby 258.973M
EBITDA -10.72
Zisk -13.42
Růst v tržbách Q/Q 66.85 %
Růst v tržbách Y/Y 9.48 %
P/E (Cena vůči ziskům) N/A
Forward P/E -5.86
EV/Sales 4.67
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 5.15
P/FCF N/A
Price/Book 4.92
Účetní hodnota na akcii 6.75
Hotovost na akcii 5.16
FCF vůči ceně -0.36 %
Počet zaměstnanců 779
Tržba na zaměstnance 332.443k
Profit margin -5.18 %
Operating margin -4.61 %
Gross margin 76.39 %
EBIT margin -4.42 %
EBITDA margin -4.14 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -67.44 %
EPS - Očekávaný růst příští rok 80.00 %
Return on assets -3.86 %
Return on equity -4.95 %
ROIC -3.30 %
ROCE -3.84 %
Dluhy/Equity 0.30
Čistý dluh/EBITDA 73.09
Current ratio 5.21
Quick Ratio 4.62
Volatilita 3.65
Beta 0.80
RSI 46.55
Cílová cena analytiků 44
Známka akcie (dle analytiků) 2.00
Insider ownership 2.99 %
Institutional ownership 96.99 %
Počet akcií 40.581M
Procento shortovaných akcií 6.25 %
Short ratio 6.22 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1981
Země United States

Finanční výsledky akcie CSII

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$236.545$248.017$217.043$204.906$178.184$181.544
Cost Of Goods Sold$48.759$47.68$39.484$39.441$35.421$39.52
Gross Profit$187.786$200.337$177.559$165.465$142.763$142.024
Research And Development Expenses$43.355$33.166$26.552$22.911$25.934$30.977
SG&A Expenses$169.969$167.7$148.569$144.096$162.542$143.684
Other Operating Income Or Expenses----$-8-
Operating Expenses$263.317$248.842$214.809$206.448$234.261$214.181
Operating Income$-26.772$-0.825$2.234$-1.542$-56.077$-32.637
Total Non-Operating Income/Expense$-0.233$0.76$-0.39$-0.164$0.145$-0.071
Pre-Tax Income$-27.005$-0.065$1.844$-1.706$-55.932$-32.708
Income Taxes$0.231$0.19$0.132$0.086$0.092$0.114
Income After Taxes$-27.236$-0.255$1.712$-1.792$-56.024$-32.822
Other Income------
Income From Continuous Operations$-27.236$-0.255$1.712$-1.792$-56.024$-32.822
Income From Discontinued Operations------
Net Income$-27.236$-0.255$1.693$-1.792$-56.024$-32.822
EBITDA$-22.702$2.566$6.168$2.593$-52.16$-30.316
EBIT$-26.772$-0.825$2.234$-1.542$-56.077$-32.637
Basic Shares Outstanding343433323332
Shares Outstanding343434323332
Basic EPS$-0.79$-0.01$0.05$-0.06$-1.72$-1.04
EPS - Earnings Per Share$-0.79$-0.01$0.05$-0.06$-1.72$-1.04
# 2020 2019 2018 2017 2016 2015
Current Ratio6.46414.25264.47443.88212.95454.4799
Long-term Debt / Capital0.07190.12420.13540.1513--
Debt/Equity Ratio0.07750.14180.15660.1782--
Gross Margin79.38780.775581.808280.751780.121178.2312
Operating Margin-11.3179-0.33261.0293-0.7525-31.4714-17.9775
EBIT Margin-11.3179-0.33261.0293-0.7525-31.4714-17.9775
EBITDA Margin-9.59731.03462.84181.2655-29.2731-16.699
Pre-Tax Profit Margin-11.4164-0.02620.8496-0.8326-31.39-18.0166
Net Profit Margin-11.5141-0.10280.78-0.8745-31.4417-18.0794
Asset Turnover0.69671.13471.06731.05651.25121.0596
Inventory Turnover Ratio1.75992.64042.37782.33422.0312.8297
Receiveable Turnover9.38226.88656.95097.19687.70435.8886
Days Sales In Receivables38.903353.002352.510950.717347.376461.9847
ROE - Return On Equity-10.1327-0.17241.2731-1.5137-55.526-23.5393
Return On Tangible Equity-10.8-0.17851.3247-1.5812-58.4289-24.3263
ROA - Return On Assets-8.0219-0.11670.8419-0.924-39.341-19.1574
ROI - Return On Investment-9.4044-0.1511.1007-1.2847-55.5259-23.5393
Book Value Per Share6.77474.23484.03093.60393.07694.3713
Operating Cash Flow Per Share-0.67680.0166-0.31731.3299-0.01610.2398
Free Cash Flow Per Share-0.6956-0.0047-0.34521.41690.51080.045